Skip to main
SNWV

SNWV Stock Forecast & Price Target

SNWV Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

SANUWAVE Health Inc. demonstrated significant financial growth in the fiscal year 2024, with a notable 60% year-over-year increase in sales, reaching a total of $32.6 million. Additionally, the company achieved an increase in Adjusted EBITDA (AEBITDA) of 28 percentage points, bringing it to 22%, indicating improved operational efficiency and profitability. While operating expenses did rise due to non-cash stock-based compensation and NASDAQ fees, the overall financial trajectory signals a strong position for SANUWAVE in the regenerative medicine market.

Bears say

The financial outlook for SANUWAVE Health appears negative due to a decline in applicator usage during the first quarter, which is typically influenced by seasonal factors such as patients postponing treatments following the reset of annual insurance deductibles. Additionally, the company faces several challenges, including margin compression, competitive pressures, and reduced sales representative productivity, which could hinder future growth. Furthermore, manufacturing setbacks could further impede operational effectiveness and sales performance, creating additional concerns for investors.

SNWV has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of SANUWAVE Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About SANUWAVE Health Inc (SNWV) Forecast

Analysts have given SNWV a Buy based on their latest research and market trends.

According to 2 analysts, SNWV has a Buy consensus rating as of Feb 7, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $55, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $55, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

SANUWAVE Health Inc (SNWV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.